Skip to main content
. Author manuscript; available in PMC: 2018 Mar 7.
Published in final edited form as: Ann Surg Oncol. 2015 Dec 17;23(5):1609–1617. doi: 10.1245/s10434-015-5012-3

TABLE 1.

Baseline and operative details

Variable n (%)
Baseline variables
Median age: years (range) 53 (20–86)
Gender
 Male 117 (47.4)
 Female 130 (52.6)
Current smoker 8 (3.2)
Median smoking pack-year history: years (range) 0 (0–50)
Median BMI: kg/m2 (range) 26.4 (18.6–48.0)
Median albumin: g/dL (range) 4.3 (2.4–5.2)
CCI: median (range) 0 (0–8)
ASA
 2 25 (10.1)
 3 126 (51.0)
 4 3 (1.2)
 NA 93 (37.7)
Primary site
 Appendix 166 (67.2)
 Colorectal 51 (20.6)
 Mesothelioma 22 (8.9)
 Ovarian 5 (2.0)
 Small bowel 3 (1.2)
Median CEA (ng/ml) 4.0 (0.2–144.0)
Symptomatic 99 (40.0)
Imaging evidence of disease 212 (85.8)
Median preoperative PCI 6 (0–38)
Prior chemotherapy 111 (44.9)
Prior resection
 None 62 (25.1)
 Yes without prior CRS-HIPEC 166 (67.2)
 Yes with prior CRS-HIPEC 19 (7.7)
Operative variables
PCI: median (range) 14 (0–29)
Median operative time: min (range) 403.5 (196–799)
Median EBL: mL (range) 250 (10–4000)
No. of visceral resections: median (range) 2 (0–10)
No. of anastomoses: median (range) 1 (0–6)
CC score
 0 199 (80.6)
 1 36 (14.6)
 2 11 (4.5)
 3 1 (0.04)
Median LOS: days (range) 10 (4–45)

BMI Body mass index, CCI Charlson comorbidity index, ASA American Society of Anesthesiology classification of physical health, NA not available, CEA carcinoembryonic antigen, PCI peritoneal cancer index, CRS-HIPEC cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, EBL estimated blood loss, CC completeness of cytoreduction, LOS hospital length of stay